cancer screening

Teaming with Massachusetts General Hospital and others, J&J's Veridex is developing a novel method of isolating cancer cells from a patient's bloodstream. If successful, the blood test could ultimately replace more invasive and painful ones such as biopsies.

A recent New York Times story is chilling enough to certainly turn the health care world upside down. The message: Cancer screenings might not save lives. In a shocking and polarizing move, the American Cancer Society is backpedaling on cancer screenings, amending its previous stance that...